Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03726320 · ClinicalTrials.gov registry record · NA
Trial of Community Health Worker-led Decision Coaching
A NA study of Prostate Cancer, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 162
- Enrollment target
- 1
- Study location
NCT03726320: Completed NA study of Prostate Cancer, sponsored by NYU Langone Health.
NCT03726320 is a NA study of Prostate Cancer that has completed, run by NYU Langone Health. The registered enrollment target is 162 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03726320, a NA study of Prostate Cancer, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 162 participants
- Enrollment target
- 1
- Study location
Study Summary
Black men are disproportionately affected by prostate cancer, the most common non-cutaneous malignancy among men in the U.S. This randomized trial will evaluate the efficacy of a Community Health Worker-led decision coaching program to facilitate Shared Decision Making (SDM) and Prostate Specific Antigen (PSA) screening among Black men with regards to decision quality, the decision making process, patient-provider communication and PSA utilization for Black men in the primary care setting.
Primary Outcome
Percentage of participants who receive at least one PSA screening. Screening data are collected through patient self-reports and electronic health record data.
Conditions Studied
Interventions
- BEHAVIORAL Education Counseling Session for PSA Screening
- BEHAVIORAL General Health Counseling Coaching
Study Locations (1)
New York
- New York University School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2019-10-15 |
| Est. Completion | 2023-09-20 |
| Phase | NA |
What the finished NCT03726320 record still lists
NCT03726320 is an interventional study that assigns participants to a tested intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Education Counseling Session for PSA Screening is the first listed.
NCT03726320 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03726320 about?
NCT03726320 is a clinical study titled "Trial of Community Health Worker-led Decision Coaching". Black men are disproportionately affected by prostate cancer, the most common non-cutaneous malignancy among men in the U.S. This randomized trial will evaluate the efficacy of a Community Health Worker-led decision coaching program to facilitate Shared Decision Making (SDM) and Prostate Specific An...
What is the current status of trial NCT03726320?
This trial is currently completed. It is a NA study. The enrollment target is 162 participants. The study started on 2019-10-15. Estimated completion is 2023-09-20.
What conditions does trial NCT03726320 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT03726320?
The interventions under investigation include: Education Counseling Session for PSA Screening (BEHAVIORAL), General Health Counseling Coaching (BEHAVIORAL).
Who is sponsoring clinical trial NCT03726320?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03726320 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03726320's enrollment target sits among peer trials
162 252nd of 735 higher than 484 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02347111 · 162 participants · Phase 4
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
- NCT02610426 · 162 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
- NCT05040711 · 162 participants · NA
mHealth Mindfulness With Patients With Serious Illness and Their Caregivers
- NCT05514717 · 162 participants · Phase 1
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI